The value of the total investment in Vitamin Shoppe, Inc decreased from $15,127,000 to $9,842,000 a change of $5,285,000 for the reporting period. The shares were purchased at an average price of $5.50 per share, for a total transaction of $220,000.00. The percentage of shares being held by the company management was 1.6% while institutional stake was 99.9%. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
About 384,577 shares traded. The stock has relative volume of 1.72. Vitamin Shoppe, Inc has a 12-month low of $5.30 and a 12-month high of $28.41.
Trading stocks at an all time low is not easy. Vident Investment Advisory Llc who had been investing in Ziopharm Oncology Inc for a number of months, seems to be less bullish one the $870.23 million market cap company.
Analysts’ mean recommendation for Vitamin Shoppe, Inc. During the same quarter previous year, the business earned $0.55 earnings per share. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The specialty retailer reported $0.23 EPS for the quarter, missing the Zacks’ consensus estimate of $0.39 by $0.16. Revenue during the quarter was $224.46 million, representing 38% growth from $163.21 million in year-ago quarter. On average, equities analysts expect that Vitamin Shoppe, Inc will post $0.79 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This news story was posted by Week Herald and is the sole property of of Week Herald. If you are reading this news story on another publication, it was illegally copied and reposted in violation of US and global copyright and trademark law. Of the analysts surveyed by Reuters that track Vitamin Shoppe, Inc.
The following firms have also recently changed their position in VSI. BNP Paribas Arbitrage SA increased its position in Vitamin Shoppe by 2.1% in the second quarter. United Services Automobile Association now owns 157,100 shares of the specialty retailer’s stock valued at $3,166,000 after buying an additional 16,700 shares during the last quarter. Municipal Employees Retirement System of MI increased its position in Vitamin Shoppe by 18.1% in the second quarter. As of quarter end Citadel Advisors LLC had acquired 94,142 shares growing its stake by 12.5%. The value of the position overall is up by 4.4%. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock valued at $3,659,000 after buying an additional 6,408 shares during the last quarter. The stock of Vitamin Shoppe Inc (NYSE:VSI) has “Hold” rating given on Thursday, November 5 by Deutsche Bank. A 0 analysts rate it as either a buy or a strong buy, while 2 believe that investors should either steer clear of (NYSE:VSI) or, if they already own its stock, sell it. Barclays PLC cut their target price on Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 10th. The stock has “Neutral” rating by JP Morgan on Thursday, October 27. Merrimack Pharmaceuticals, Inc. has 0 buy ratings, 3 holds and 0 sells even after the stock tumbled -70.77% from its high of $6.79 to a $179.28 million market value through last close. The average 1-year price target for (VSI) reveals an average price target of $7.33 per share. Wedbush initiated Vitamin Shoppe Inc (NYSE:VSI) on Thursday, April 21 with “Outperform” rating.